Hyperthermia Cancer Treatment Market

Hyperthermia Cancer Treatment Market (Device Type: Infrared Hyperthermia Devices, Ultrasound Hyperthermia Devices, Microwave Hyperthermia Devices, and Others; Treatment Method: Locoregional Method and Whole-body; Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, and Others; and End User: Hospitals & Specialty Clinics, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Rise in Investments in Telemedicine for Access to Cancer Care during COVID-19

Healthcare costs seem to have increased for cancer patients amid the ongoing coronavirus situation, since these patients are at the high risk of contracting the infection, owing to low immunity levels. This has created revenue opportunities for companies in the hyperthermia cancer treatment market, as clinicians have boosted their capabilities in telemedicine and other digital platforms to increase accessibility to patient care.

Hospitals and specialty clinics are increasing their investments in developing special screening departments for the evaluation of cancer patients with potential COVID-19 symptoms. Such trends are generating business streams in order to revive growth of the hyperthermia cancer treatment market. However, many clinics have limited and even excluded the amount of visitors that are at the low risk of COVID-19.

hyperthermia cancer treatment market segmentation

Request a sample to get extensive insights into the Hyperthermia Cancer Treatment Market

Scientists Address Undesired Crystalline Phases in Glass Ceramics for Hyperthermia Techniques

Companies in the hyperthermia cancer treatment market are increasing their R&D in new treatment options for patients. This has led to the emergence of glass ceramics for hyperthermia techniques, owing to their advantages of biocompatibility, bioactivity, and osteoproductivity. However, scientists are yet to explore ways to prevent the occurrence of undesired crystalline phases in the material. Companies are partnering with researchers and scientists to prevent the magnetite oxidation to hematite, which can emerge, while undergoing the heat treatment.

The hyperthermia cancer treatment market is slated to register a favorable CAGR of ~6% during the forecast period. This is evident since glass ceramics in hyperthermia techniques are capable of raising the temperature of cancerous tissues high enough to destroy it.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Deep Tissue Thermal Therapy Holds Promising Potentials in Breast Cancer Treatment

The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer. The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), U.S., is gaining recognition for its comprehensive and individualized thermal therapy works. This indicates that med-tech companies are unlocking growth opportunities in the U.S., since North America is anticipated to dictate the highest revenue share among all regions in the market. The deep tissue therapy is being combined with the proton therapy to improve medical outcomes.

hyperthermia cancer treatment market infographic

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hyperthermia Cancer Treatment Market

Ultrasound Hyperthermia Devices Provide Quality Assurance for Treatment of Cancer Patients

The therapeutic application of heat is found to be effective in cancer treatment. Hence, med-tech companies in the hyperthermia cancer treatment market are increasing their production capacities in high quality heating equipment to enable precise thermal dosimetry. This has led to innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.

High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies in the hyperthermia cancer treatment market. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.

Strong R&D in Operating Principles of Internal Heating Techniques Improves Medical Outcomes

Combination treatments such as hyperthermia with chemotherapy via controlled localized heating can be achieved with the help of radiofrequency (RF) and microwave. Recent advancements in radiofrequency and microwave mediated hyperthermia include applicators that are most suitable for superficial hyperthermia. On the other hand, internal heating or deep hyperthermia is being combined with brachytherapy i.e. a needle-shaped antenna/electrode that can be implanted directly in the tissue or inserted via catheters.

The high variety in applicator designs for internal heating such as microwave antennas, capacitive-coupled RF catheter-based electrodes, and ultrasound systems are creating value grab opportunities for companies in the hyperthermia cancer treatment market. Med-tech companies are gaining a strong research in operating principles of internal heating techniques and other devices.

Analysts’ Viewpoint

Telemedicine and mobile apps are offering wellness and stress management resources to cancer patients amid the ongoing COVID-19 pandemic. Companies in the hyperthermia cancer treatment market are benefitting with the help of the deep tissue thermal therapy, owing to its non-invasive nature that omits the need of anesthesia. However, radiation dose weighting-based on clonogenic cell survival analysis alone may not be sufficient to predict treatment efficacy. Hence, companies in the hyperthermia cancer treatment market should increase their R&D in more sophisticated biological dose concepts based on spheroid data to improve patient outcomes. Glass ceramics are a breakthrough innovation in the hyperthermia cancer treatment that hold promising potentials with advancements in biomaterial R&D.

Hyperthermia Cancer Treatment Market: Overview

  • Hyperthermia is a form of therapy where heat is used to enhance effectiveness of radiation and chemotherapy, and to destroy tumors. Hyperthermia is most often used to treat tumors that are close to the surface of the body. In the hyperthermia treatment, the tumor area is heated to a temperature of 40 degree Celsius to 43 degree Celsius (104 degree Fahrenheit to 109 degree Fahrenheit) for approximately one hour.
  • Recently, several clinical trials showed that hyperthermia with radiation therapy and/or chemotherapy for the treatment of recurrent breast cancer, melanoma, head & neck cancer, prostate, cervix, and other sites of locally advanced or recurrent cancers provides additional benefits with lower side effects to destroy cancer cells
  • Different types of devices used for hyperthermia treatment includes infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others
  • The global hyperthermia cancer treatment market has experienced significant growth in the last decade due to rise in prevalence of various types of cancer and favorable policies

Hyperthermia Cancer Treatment Market: Drivers

  • Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NIH), an estimated 1,806,590 cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer likely to account for 43% of the total cancer cases in men. More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions.
  • Increase in the geriatric population directly affects the global hyperthermia cancer treatment market. The population aged 65 years and above has higher cancer incidence and mortality rate than younger people. Around 60% of cancer conditions occur among the geriatric population, 10 to 11 times higher than in the younger population.

Market Segmentation: Hyperthermia Cancer Treatment Market

  • In terms of device type, the global hyperthermia cancer treatment market has been divided into infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others. The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period.
  • Based on treatment method, the global hyperthermia cancer treatment market has been bifurcated into locoregional and whole-body. The locoregional segment has been split into external & interstitial, intraluminal or endocavitary methods, continuous hyperthermic peritoneal perfusion (CHPP), and deep tissue & regional perfusion.
  • In terms of application, the global hyperthermia cancer treatment market has been classified into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others
  • Based on end user, the global hyperthermia cancer treatment market has been categorized into hospitals & specialty clinics, ambulatory surgical centers, and others. The hospitals & specialty clinics segment dominated the global hyperthermia cancer treatment market in terms of revenue in 2019.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and expected revenue (US$ Mn) for each of these segments from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Hyperthermia Cancer Treatment Market

  • In terms of region, the global hyperthermia cancer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market revenue (US$ Mn) of these regional markets and their major countries have been provided in the report from 2018 to 2030, with their CAGRs from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the global hyperthermia cancer treatment market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Hyperthermia Cancer Treatment Market: Major Players

  • The hyperthermia cancer treatment market report concludes with the company profiles section, which includes key information about major players in the global hyperthermia cancer treatment market
  • Leading players analyzed in the hyperthermia cancer treatment market report include
    • Pyrexar Medical
    • Celsius42 GmbH
    • Hydrosun GmbH
    • Oncotherm Kft
    • Andromedic S.r.l.
    • Yamamoto Vinita Co., Ltd.
    • Chongqing Haifu Medical Technology Co., Ltd.
    • innoMedicus Ltd.
    • Gamida
    • RanD
  • Each of these players has been profiled in the hyperthermia cancer treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Hyperthermia Cancer Treatment Market - Segmentation

TMR’s study on the global hyperthermia cancer treatment market includes information divided into five segments: device type, treatment method, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global hyperthermia cancer treatment market are discussed in detail.

Device Type

  • Infrared Hyperthermia Devices
  • Ultrasound Hyperthermia Devices
  • Microwave Hyperthermia Devices
  • Others
Treatment Method
  • Locoregional Method
    • External & Interstitial
    • Intraluminal or Endocavitary Methods
    • Continuous Hyperthermic Peritoneal Perfusion (CHPP)
    • Deep Tissue & Regional Perfusion
  • Whole-body
Application
  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others
End User
  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of hyperthermia cancer treatment market?

Hyperthermia cancer treatment market to cross valuation of US$ 266 Mn by 2030

What is the anticipated CAGR of the hyperthermia cancer treatment market in the forecast period?

Hyperthermia cancer treatment market is projected to expand at a CAGR of ~6% from 2020 to 2030

What are the key driving factors for the growth of the hyperthermia cancer treatment market?

Hyperthermia cancer treatment market is driven by rise in prevalence and incidence of cancers

Which is the rising prominent segment in the hyperthermia cancer treatment market?

The microwave hyperthermia devices segment is projected to dominate the global hyperthermia cancer treatment market during the forecast period

Who are the key players in the global hyperthermia cancer treatment market?

Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l.

    1. Preface

        1.1. Report Scope and Market Segmentation

        1.2. Research Highlights

    2. Assumptions and Research Methodology

        2.1. Assumptions and Acronyms Used

        2.2. Research Methodology

    3. Executive Summary

    4. Market Overview

        4.1. Introduction

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunity

        4.3. Global Hyperthermia Cancer Treatment Market Forecast

        4.4. Global Hyperthermia Cancer Treatment Market Outlook

    5. Market Outlook

        5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

        5.2. Epidemiology of Cancer Globally/Country

        5.3. Reimbursement Scenario 

        5.4. Regulatory Scenario 

        5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia

    6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

        6.1. Introduction

        6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type

            6.3.1. Infrared Hyperthermia Devices

            6.3.2. Ultrasound Hyperthermia Devices

            6.3.3. Microwave Hyperthermia Devices

            6.3.4. Others

        6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

    7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

        7.1. Introduction 

        7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            7.3.1. Locoregional

                7.3.1.1. External & Interstitial

                7.3.1.2. Intraluminal or Endocavitary Methods

                7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                7.3.1.4. Deep Tissue & Regional Perfusion

            7.3.2. Whole-body

        7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

    8. Global Hyperthermia Cancer Treatment Market Analysis, by Application

        8.1. Introduction 

        8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application

            8.3.1. Breast Cancer

            8.3.2. Liver Cancer

            8.3.3. Soft Tissue Sarcoma

            8.3.4. Head & Neck Tumors

            8.3.5. Prostate Cancer

            8.3.6. Others

        8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application

    9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

        9.1. Introduction

        9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user

            9.3.1. Hospitals & Specialty Clinics

            9.3.2. Ambulatory Surgical Centers

            9.3.3. Others

        9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

    10. Global Hyperthermia Cancer Treatment Market Analysis, by Region

        10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country

        10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region

        10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region

            10.3.1. North America

            10.3.2. Europe

            10.3.3. Asia Pacific

            10.3.4. Latin America

            10.3.5. Middle East & Africa

    11. North America Hyperthermia Cancer Treatment Market Analysis

        11.1. North America Hyperthermia Cancer Treatment Market Overview

        11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country

        11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country

            11.3.1. U.S.

            11.3.2. Canada

        11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type

            11.5.1. Infrared Hyperthermia Devices

            11.5.2. Ultrasound Hyperthermia Devices

            11.5.3. Microwave Hyperthermia Devices

            11.5.4. Others

        11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            11.7.1. Locoregional

                11.7.1.1. External & Interstitial

                11.7.1.2. Intraluminal or Endocavitary Methods

                11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                11.7.1.4. Deep Tissue & Regional Perfusion

            11.7.2. Whole-body

        11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application

            11.9.1. Breast Cancer

            11.9.2. Liver Cancer

            11.9.3. Soft Tissue Sarcoma

            11.9.4. Head & Neck Tumors

            11.9.5. Prostate Cancer

            11.9.6. Others

        11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user

            11.11.1. Hospitals & Specialty Clinics

            11.11.2. Ambulatory Surgical Centers

            11.11.3. Others 

    12. Europe Hyperthermia Cancer Treatment Market Analysis

        12.1. Europe Hyperthermia Cancer Treatment Market Overview

        12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

        12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

            12.3.1. Germany

            12.3.2. France

            12.3.3. U.K.

            12.3.4. Italy

            12.3.5. Spain

            12.3.6. Rest of Europe

        12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type

            12.5.1. Infrared Hyperthermia Devices

            12.5.2. Ultrasound Hyperthermia Devices

            12.5.3. Microwave Hyperthermia Devices

            12.5.4. Others

        12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            12.7.1. Locoregional

                12.7.1.1. External & Interstitial

                12.7.1.2. Intraluminal or Endocavitary Methods

                12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                12.7.1.4. Deep Tissue & Regional Perfusion

            12.7.2. Whole-body

        12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application

            12.9.1. Breast Cancer

            12.9.2. Liver Cancer

            12.9.3. Soft Tissue Sarcoma

            12.9.4. Head & Neck Tumors

            12.9.5. Prostate Cancer

            12.9.6. Others

        12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user

            12.11.1. Hospitals & Specialty Clinics

            12.11.2. Ambulatory Surgical Centers

            12.11.3. Others 

    13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis

        13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview

        13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

        13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

            13.3.1. Japan

            13.3.2. China

            13.3.3. India

            13.3.4. Australia & New Zealand

            13.3.5. Rest of Asia Pacific

        13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type

            13.5.1. Infrared Hyperthermia Devices

            13.5.2. Ultrasound Hyperthermia Devices

            13.5.3. Microwave Hyperthermia Devices

            13.5.4. Others

        13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            13.7.1. Locoregional

                13.7.1.1. External & Interstitial

                13.7.1.2. Intraluminal or Endocavitary Methods

                13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                13.7.1.4. Deep Tissue & Regional Perfusion

            13.7.2. Whole-body

        13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application

            13.9.1. Breast Cancer

            13.9.2. Liver Cancer

            13.9.3. Soft Tissue Sarcoma

            13.9.4. Head & Neck Tumors

            13.9.5. Prostate Cancer

            13.9.6. Others

        13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user

            13.11.1. Hospitals & Specialty Clinics

            13.11.2. Ambulatory Surgical Centers

            13.11.3. Others 

    14. Latin America Hyperthermia Cancer Treatment Market Analysis

        14.1. Latin America Hyperthermia Cancer Treatment Market Overview

        14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

        14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

            14.3.1. Brazil

            14.3.2. Mexico

            14.3.3. Rest of Latin America

        14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type

            14.5.1. Infrared Hyperthermia Devices

            14.5.2. Ultrasound Hyperthermia Devices

            14.5.3. Microwave Hyperthermia Devices

            14.5.4. Others

        14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            14.7.1. Locoregional

                14.7.1.1. External & Interstitial

                14.7.1.2. Intraluminal or Endocavitary Methods

                14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                14.7.1.4. Deep Tissue & Regional Perfusion

            14.7.2. Whole-body

        14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application

            14.9.1. Breast Cancer

            14.9.2. Liver Cancer

            14.9.3. Soft Tissue Sarcoma

            14.9.4. Head & Neck Tumors

            14.9.5. Prostate Cancer

            14.9.6. Others

        14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user

            14.11.1. Hospitals & Specialty Clinics

            14.11.2. Ambulatory Surgical Centers

            14.11.3. Others

    15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis

        15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview

        15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

        15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

            15.3.1. GCC Countries

            15.3.2. South Africa

            15.3.3. Rest of Middle East & Africa

        15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

        15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type

            15.5.1. Infrared Hyperthermia Devices

            15.5.2. Ultrasound Hyperthermia Devices

            15.5.3. Microwave Hyperthermia Devices

            15.5.4. Others

        15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

        15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

            15.7.1. Locoregional

                15.7.1.1. External & Interstitial

                15.7.1.2. Intraluminal or Endocavitary Methods

                15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

                15.7.1.4. Deep Tissue & Regional Perfusion

            15.7.2. Whole-body

        15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

        15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application

            15.9.1. Breast Cancer

            15.9.2. Liver Cancer

            15.9.3. Soft Tissue Sarcoma

            15.9.4. Head & Neck Tumors

            15.9.5. Prostate Cancer

            15.9.6. Others

        15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

        15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user

            15.11.1. Hospitals & Specialty Clinics

            15.11.2. Ambulatory Surgical Centers

            15.11.3. Others

    16. Competition Landscape

        16.1. Competition Matrix

        16.2. Company Profiles

            16.2.1. Pyrexar Medical

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Product Portfolio

                16.2.1.3. SWOT Analysis

                16.2.1.4. Strategic Overview

            16.2.2. Celsius42 GmbH

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Product Portfolio

                16.2.2.3. SWOT Analysis

                16.2.2.4. Strategic Overview

            16.2.3. Hydrosun GmbH

                16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.3.2. Product Portfolio

                16.2.3.3. SWOT Analysis

                16.2.3.4. Strategic Overview

            16.2.4. Oncotherm Kft

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Product Portfolio

                16.2.4.3. SWOT Analysis

                16.2.4.4. Strategic Overview

            16.2.5. Andromedic S.r.l.

                16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.5.2. Product Portfolio

                16.2.5.3. SWOT Analysis

                16.2.5.4. Strategic Overview

            16.2.6. Yamamoto Vinita Co., Ltd.

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Product Portfolio

                16.2.6.3. SWOT Analysis

                16.2.6.4. Strategic Overview

            16.2.7. Chongqing Haifu Medical Technology Co., Ltd

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Product Portfolio

                16.2.7.3. SWOT Analysis

                16.2.7.4. Strategic Overview

            16.2.8. innoMedicus Ltd.

                16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.8.2. Product Portfolio

                16.2.8.3. SWOT Analysis

                16.2.8.4. Strategic Overview

            16.2.9. Gamida

                16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.9.2. Product Portfolio

                16.2.9.3. SWOT Analysis

                16.2.9.4. Strategic Overview

            16.2.10. RanD.

                16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.10.2. Product Portfolio

                16.2.10.3. SWOT Analysis

                16.2.10.4. Strategic Overview

    List of Tables

    Table 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

    Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

    Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030

    Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

    Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030

    Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

    Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030

    Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030

    Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030

    Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    List of Figures

    Figure 01: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, 2018–2030

    Figure 02: Global Hyperthermia Cancer Treatment Market Value Share, by Device Type, 2019

    Figure 03: Global Hyperthermia Cancer Treatment Market Value Share, by Treatment Method, 2019

    Figure 04: Global Hyperthermia Cancer Treatment Market Value Share, by Application, 2019

    Figure 05: Global Hyperthermia Cancer Treatment Market Value Share, by End-user, 2019

    Figure 06: Global Hyperthermia Cancer Treatment Market Value Share, by Region, 2019

    Figure 07: Global New Cancer Cases & Deaths, 2017 

    Figure 08: Incidence of Breast Cancer, by Country

    Figure 09: Prevalence of Breast Cancer, by Country

    Figure 10: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 11: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 12: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Infrared Hyperthermia Devices, 2018–2030

    Figure 13: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ultrasound Hyperthermia Devices, 2018–2030

    Figure 14: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Microwave Hyperthermia Devices, 2018–2030

    Figure 15: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030

    Figure 16: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 17: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

    Figure 18: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Locoregional, 2018–2030

    Figure 19: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Whole-Body, 2018–2030

    Figure 20: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 21: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 22: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Breast Cancer, 2018–2030

    Figure 23: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Liver Cancer, 2018–2030

    Figure 24: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Soft Tissue Sarcoma, 2018–2030

    Figure 25: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Head & Neck Tumors, 2018–2030

    Figure 26: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Prostate Cancer, 2018–2030

    Figure 27: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Others, 2018–2030

    Figure 28: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 29: Global Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030

    Figure 30: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Hospitals & Specialty Clinics, 2018–2030

    Figure 31: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2018–2030

    Figure 32: Global Hyperthermia Cancer Treatment Market Revenue (US$ Mn), by Standalone Devices, 2018–2030

    Figure 33: Global Hyperthermia Cancer Treatment Market Value Share Analysis, by Region, 2019 and 2030

    Figure 34: Global Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Region

    Figure 35: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 36: North America Hyperthermia Cancer Treatment Market Value Share (%), by Country, 2019 and 2030

    Figure 37: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country, 2020–2030

    Figure 38: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 39: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 40: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 41: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–203041

    Figure 42: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 43: North America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 44: North America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 45: North America Hyperthermia Cancer Treatment Market Attractiveness, by End-user, 2020–2030

    Figure 46: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 47: Europe Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

    Figure 48: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 49: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 50: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 51: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 52: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

    Figure 53: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 54: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 55: Europe Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 56: Europe Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 57: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 58: Asia Pacific Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

    Figure 59: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 60: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 61: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 62: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 63: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

    Figure 64: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 65: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 66: Asia Pacific Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 67: Asia Pacific Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 68: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 69: Latin America Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

    Figure 70: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 71: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 72: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 73: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 74: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

    Figure 75: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 76: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 77: Latin America Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 78: Latin America Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 79: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 80: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share (%), by Country/Sub-region, 2019 and 2030

    Figure 81: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

    Figure 82: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Device Type, 2019 and 2030

    Figure 83: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Device Type, 2020–2030

    Figure 84: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Treatment Method, 2019 and 2030

    Figure 85: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Treatment Method, 2020–2030

    Figure 86: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by Application, 2019 and 2030

    Figure 87: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by Application, 2020–2030

    Figure 88: Middle East & Africa Hyperthermia Cancer Treatment Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 89: Middle East & Africa Hyperthermia Cancer Treatment Market Attractiveness Analysis, by End-user, 2020–2030

Copyright © Transparency Market Research, Inc. All Rights reserved